Cancer Biopsy Market Size, Share & Trends Report

Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Core Needle Biopsy), By Application (Breast Cancer, Lung Cancer), By Product (Kits & Consumables, Instruments), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-254-2
Number of Pages: 140
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Cancer Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
- Kits and Consumables
- Services
Cancer Biopsy Type Outlook (Revenue, USD Million, 2018 - 2030)
- Tissue Biopsies
  - Needle Biopsies
    - Fine Needle Aspiration (FNA)
    - Core Needle Biopsy (CNB)
  - Surgical Biopsies
- Liquid Biopsies
- Others
Cancer Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Colorectal Cancer
- Cervical Cancers
- Lung Cancers
- Prostate Cancers
- Skin Cancers
- Blood Cancers
- Kidney Cancers
- Liver Cancers
- Pancreatic Cancers
- Ovarian Cancers
- Others
Cancer Biopsy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America cancer biopsy market, by product, (USD Million, 2018 - 2030)
    - Instruments
    - Kits and Consumables
    - Services
  - North America cancer biopsy market, by type, (USD Million, 2018 - 2030)
    - Tissue Biopsies
      - Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
      - Surgical Biopsies
    - Liquid Biopsies
    - Others
  - North America cancer biopsy market, by application, (USD Million, 2018 - 2030)
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancers
    - Lung Cancers
    - Prostate Cancers
    - Skin Cancers
    - Blood Cancers
    - Kidney Cancers
    - Liver Cancers
    - Pancreatic Cancers
    - Ovarian Cancers
    - Others
  - U.S.
  - Canada
    - Canada cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Canada cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Canada cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
- Europe
  - Europe cancer biopsy market, by product, (USD Million, 2018 - 2030)
    - Instruments
    - Kits and Consumables
    - Services
  - Europe cancer biopsy market, by type, (USD Million, 2018 - 2030)
    - Tissue Biopsies
      - Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
      - Surgical Biopsies
    - Liquid Biopsies
    - Others
  - Europe cancer biopsy market, by application, (USD Million, 2018 - 2030)
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancers
    - Lung Cancers
    - Prostate Cancers
    - Skin Cancers
    - Blood Cancers
    - Kidney Cancers
    - Liver Cancers
    - Pancreatic Cancers
    - Ovarian Cancers
    - Others
  - UK
    - UK cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - UK cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - UK cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Germany
    - UK cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Germany cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Germany cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - France
    - France cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - France cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - France cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Italy
    - Italy cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Italy cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Italy cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Spain
    - Spain cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Spain cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Spain cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Denmark
    - Denmark cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Denmark cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Denmark cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Sweden
    - Sweden cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Sweden cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Sweden cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Norway
    - Norway cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Norway cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Norway cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
- Asia Pacific
- Latin America
  - Latin America cancer biopsy market, by product, (USD Million, 2018 - 2030)
    - Instruments
    - Kits and Consumables
    - Services
  - Latin America cancer biopsy market, by type, (USD Million, 2018 - 2030)
    - Tissue Biopsies
      - Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
      - Surgical Biopsies
    - Liquid Biopsies
    - Others
  - Latin America cancer biopsy market, by application, (USD Million, 2018 - 2030)
    - Breast Cancer
    - Colorectal Cancer
    - Cervical Cancers
    - Lung Cancers
    - Prostate Cancers
    - Skin Cancers
    - Blood Cancers
    - Kidney Cancers
    - Liver Cancers
    - Pancreatic Cancers
    - Ovarian Cancers
    - Others
  - Brazil
    - Brazil cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Brazil cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Brazil cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Mexico
    - Mexico cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Mexico cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Mexico cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
  - Argentina
    - Argentina cancer biopsy market, by product, (USD Million, 2018 - 2030)
      - Instruments
      - Kits and Consumables
      - Services
    - Argentina cancer biopsy market, by type, (USD Million, 2018 - 2030)
      - Tissue Biopsies
        
        Needle Biopsies
        
        Fine Needle Aspiration (FNA)
        
        Core Needle Biopsy (CNB)
        
        Surgical Biopsies
      - Liquid Biopsies
      - Others
    - Argentina cancer biopsy market, by application, (USD Million, 2018 - 2030)
      - Breast Cancer
      - Colorectal Cancer
      - Cervical Cancers
      - Lung Cancers
      - Prostate Cancers
      - Skin Cancers
      - Blood Cancers
      - Kidney Cancers
      - Liver Cancers
      - Pancreatic Cancers
      - Ovarian Cancers
      - Others
- Middle East & Africa

Cancer Biopsy Market Dynamics

Drivers: Advent Of Liquid Biopsy

In the coming years, liquid biopsy is expected to grow exponentially, with biopharmaceutical manufacturing and genomic data analysis companies becoming increasingly involved in investments and strategic initiatives. For instance, in early 2018, Seven Bridges Genomics—a company engaged in biomedical data analysis—announced its plan to enter the liquid biopsy market space. Such emerging companies are inclined toward collaborating with well-established liquid biopsy industry participants, including SOPHiA Genetics, QIAGEN Bioinformatics, Agilent Technologies, and Fabric Genomics. This trend is further expected to favor the overall growth of the cancer biopsy market.

The field of liquid biopsies is rapidly growing, involving noninvasive tests for patients with or at risk of developing cancer. Liquid biopsies can facilitate early cancer detection and real-time evaluation of potential treatments' efficacy. The emergence of biomarker-based diagnostics is anticipated to improve the fluid biopsy field. Diagnostic developers are collaborating with research institutes to develop liquid biopsies and to deliver insights into the progression, detection, and treatment options for cancer patients.

Transition Of Novel Oncology Diagnostics From Bench To Clinics

Novel diagnostic and therapeutic oncology technologies are penetrating both across benchtop settings and gaining significant demand in clinics. Several novel diagnostic technologies developed recently can transform oncology treatment and diagnosis. This has caught the attention of several care providers, regulators, and manufacturers, further increasing investments in this area. Approximately 8 million cancer patients die annually, which has strained the healthcare systems across the globe. The global oncology spending is anticipated to reach nearly USD 240 billion by 2023. This offers a tremendous opportunity for cancer biopsy manufacturers to establish their market presence as the need to manage cancer burden effectively becomes imperative.

Restraints: Risks Associated With Biopsy Procedures

Accurate detection of the progression of cancer is very important for the selection of an appropriate treatment regimen. Presently, available tests show false-positive results in some cases. Thus, supportive confirmatory tests must be performed, increasing patients' monetary burden. Tests using specific biomarkers and tumor markers give comparatively more accurate results. However, specific biomarkers and tumor biomarkers are not abundantly available. As a result, the lack of susceptible tests is impeding market growth. Diagnostic tests for cancer are costly and increase the financial burden on the families of patients. The government insurance framework is not as well-defined in developing countries as it is in developed countries. Thus, these tests are not affordable for a middle-class patient population that is not covered under any insurance (private or government). In addition, many private insurance players do not cover the costs associated with a cancer diagnosis in these countries. As a result, high cost of diagnosis is limiting the adoption of cancer screening tools, especially in developing countries. However, the scenario is expected to change in the coming years owing to booming medical tourism in these countries, such as India and Malaysia, where healthcare treatments and diagnostic solutions are becoming affordable.

What Does This Report Include?

This section will provide insights into the contents included in this cancer biopsy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Cancer biopsy market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Cancer biopsy market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.